Livzon Pharmaceutical Group appeared to be the Corporate Investor, which was created in 1985. The main office of represented Corporate Investor is situated in the Zhuhai. The fund was located in Asia if to be more exact in China.
Among the most popular fund investment industries, there are Medical, Health Diagnostics. For fund there is no match between the location of its establishment and the land of its numerous investments - United States. The fund has no specific favorite in a number of founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight Elicio Therapeutics, Cynvenio Biosystems. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund.
The standard case for the fund is to invest in rounds with 2-3 partakers. The meaningful sponsors for the fund in investment in the same round are Syno Capital, Greenwoods Asset Management, EFung Capital.
The important activity for fund was in 2015. Considering the real fund results, this Corporate Investor is 47 percentage points more often commits exit comparing to other organizations. The usual things for fund are deals in the range of 10 - 50 millions dollars. The fund is generally included in less than 2 deals every year.
|Alfa Ventures||India, Delhi|
|Qianshan Capital||China, Chaoyang|
|Resolute Ventures||United States, San Francisco|
|Korea Thrunet Co||South Korea, Seoul|
|Westcott LLC||United States, Dallas|
|Milestone Capital Partners||United Kingdom, London|
|Viscogliosi Brothers||United States, New York|
|Lan Fund||China, Beijing|
|Ann Arbor Angels||United States, Ann Arbor|
|DoubleLine Equity Healthcare Fund||-|
|Quintus Vermoegensverwaltung GmbH||-|
|Huihua Investment||China, Fenghua|
|Almeda Ventures||Israel, Tel Aviv|
|Qicheng Chuang Tou||China, Dongguan|
|Lianhe Zhongan Wenhua||China, Haidian|
|Startup:Education||United States, Newark|
|Shenzhen Shi Qianhai Dingdian Jinrong||China, Shenzhen|
|Thurston Group||United States, Chicago|
|$47M||07 Jan 2021||United States, Philadelphia|
Atom Bioscience & Pharmaceutical
|$30M||27 May 2020||China, Zhenjiang|
|$33M||02 Oct 2019||United States, Cambridge|
|27 Jun 2018||China, Xiangzhou District|
|$25M||17 Jun 2015||United States, " United States"}|
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.